CERo Therapeutics Holdings, Inc. Common Stock (CERO) — Cash Flow Quality Index

Latest as of September 2022: -2.06x

CERo Therapeutics Holdings, Inc. Common Stock (CERO) has a Cash Flow Quality Index of -2.06x as of September 2022. Operating cash flow of $-174.35K is below net income of $84.50K, suggesting accrual-heavy earnings not yet converted to cash. Explore CERO cash flow conversion to assess how effectively this company generates cash.

Cash Flow Quality Index

-2.06x

Operating CF / Net Income

Operating Cash Flow

$-174.35K

USD

Net Income

$84.50K

USD

Data as of

Sep 2022

Most recent filing

Annual Cash Flow Quality Index for CERo Therapeutics Holdings, Inc. Common Stock (None–None)

Year-by-year earnings quality comparison for CERo Therapeutics Holdings, Inc. Common Stock. For live market cap and the full company financial profile, see CERo Therapeutics Holdings, Inc. Common (CERO) total market value.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.